ISCO stock

International Stem Cell Corp (ISCO) financials · rev $5.0M

International Stem Cell Corp (ISCO) rev $5.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$9.1M$9.1M
Cost of Revenue$4.0M$3.8M
Gross Profit$5.1M$5.3M
Operating Income-$267.0K-$68.0K
Net Income-$418.0K-$209.0K
EPS (Diluted)$-0.05$-0.03
Cached annual balance sheet
LineFY2025FY2024
Total Assets$4.8M$5.2M
Current Assets$3.4M$3.6M
Cash & Equivalents$993.0K$1.2M
Inventory$1.5M$1.1M
PP&E$160.0K$257.0K
Total Liabilities$4.6M$4.8M
Current Liabilities$4.6M$4.7M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$4.1M-$3.9M
Retained Earnings-$111.1M-$110.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$8.0K$13.0K
CapEx$43.0K$166.0K
Investing Cash Flow-$45.0K-$171.0K
Financing Cash Flow-$200.0K-$200.0K
Dividends Paid$0$0
Net Change in Cash-$237.0K-$358.0K
Free Cash Flow-$35.0K-$153.0K

FAQ

What is ISCO P/E and revenue?

International Stem Cell Corp (ISCO) rev $5.0M.

What is ISCO revenue?

International Stem Cell Corp last cached revenue is $9.1M (FY2025).

Is ISCO profitable?

International Stem Cell Corp last cached net income is -$418.0K.

What are ISCO total assets?

International Stem Cell Corp last cached total assets are $4.8M.

What is ISCO free cash flow?

International Stem Cell Corp last cached free cash flow is -$35.0K.

Not investment advice. Cached statements, not a live tape.